The company is subject to general risks and uncertainties that affect many other companies, including market conditions, economic conditions, geopolitical events, and disruptions of expected business conditions. These factors may impair the business, including results of operations, liquidity, financial condition, and stock price. The company continues to monitor key competitors and customers to gauge relative performance and the outlook for the future. The company is making significant investments to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development, and customer-facing resources to improve operational efficiency. The company’s operations are affected by worldwide, regional, and industry-specific economic and political factors, which help limit the impact of any one industry or economy on its consolidated operating results. The company anticipates that the indebtedness incurred in connection with acquisitions will result in a negative change to its credit ratings compared to prior ratings, which may limit its ability to borrow at favorable interest rates. The company’s business is sensitive to general economic conditions, and slower global economic growth can adversely affect the company and its distributors, customers, and suppliers. The company faces intense competition and must retain longstanding relationships with major customers while continually developing new products and services to maintain and expand its brand recognition. The company’s growth depends on the timely development and commercialization of new and enhanced products and services based on technological innovation. The company has established policies and procedures designed to assist with compliance with laws and regulations, but cannot assure that these will prevent violations that could adversely affect its reputation and financial statements. The company’s restructuring activities can have long-term adverse effects on its business, including reducing available talent and resources, which may limit its ability to respond to customers and increase production quickly. The company’s financial results are subject to fluctuations in the cost and availability of commodities used in its operations, and any sustained interruption in supply could adversely affect the business. The company is exposed to risks associated with public health crises and epidemics, which could adversely impact operations, supply chains, and distribution systems. The company has increased its level of inventory to mitigate potential impacts from geopolitical events such as Brexit. The company’s operations, products, and services expose it to environmental, health, and safety liabilities that could adversely affect its reputation and financial statements. The company’s ability to obtain regulatory clearances or approvals for new products is subject to many factors, including the ability to obtain necessary clinical trial results, and failure to meet regulatory requirements could lead to significant penalties. The company relies on collaborative relationships with third parties for development and marketing, and any failure of these partners to perform could adversely affect the business. The company’s ability to grow revenues and earnings depends on its ability to identify and successfully acquire and integrate businesses, and any inability to consummate acquisitions could negatively impact its growth rate and stock price. The company’s financial condition and results of operations can be adversely affected by litigation and other legal proceedings, and it cannot assure that liabilities in connection with these matters will not exceed estimates. The company continues to assess the strategic fit of its existing businesses and may divest those not achieving the desired return on investment, which could also negatively impact its financial statements.